Article

Expansion, persistence and efficacy of donor memory-like NK cells for the treatment of post-transplant relapse

2021-08-30

Abstract excerpt

<h4>Background</h4> Responses to conventional donor lymphocyte infusion (DLI) for post-allogeneic hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell-based therapy is a promising modality to treat post-HCT relapse. <h4>Methods</h4> We initiated this ongoing phase 1 trial of adoptively transferred c ytokine i nduced m emory- l ike (CIML) NK cells in patients with myeloid ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86e1712c-a6d4-5808-89b1-8f707fc459a3
DOI: 10.1101/2021.08.24.21262547

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Expansion, persistence and efficacy of donor memory-like NK cells for the treatment of post-transplant relapseDOI 10.1101/2021.08.24.21262547Read

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantationSemantic proximity Read

Immune Escape of Relapsed AML Cells after Allogeneic TransplantationSemantic proximity Read

Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.Semantic proximity Read

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancerSemantic proximity Read

Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and PersistenceSemantic proximity Read

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular TherapySemantic proximity Read

Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand.Semantic proximity Read

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity Read

KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.Semantic proximity Read

Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.Semantic proximity Read

Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.Semantic proximity Read

Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy.Semantic proximity Read